$3.09 -0.05 (-1.59%)
2/10/2012 4:00 PM

Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Featured Broker Partners


Advertisement